[Source: Fierce Pharma ] January 2025 The FDA fast-tracked tirzepatide for cardiovascular risk reduction in obesity patients, following landmark trial results showing significant benefit beyond weight loss
A person with a BMI of 28 and a history of gestational diabetes may benefit from one of these medications to lose weight while concomitantly mastering lifestyle behaviors, and then transition off the weight management medications to lifestyle alone, says Linda Gigliotti, MS, RDN, CDCES, CSOWM, an obesity and weight management specialist based in Irvine, California
Retatrutide Starter Kit for single-vial research setups
[3] Step 4: Treatment Plan & Shipping Once approved, Hers outlines your treatment plan and ships your medication directly to your door
These are topline figures from the company, not the full published data, and retatrutide isnt approved anywhere yet